Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Screening impacts of Tilmicosin-induced hepatic and renal toxicity in rats: protection by Rhodiola rosea extract through the involvement of oxidative stress, antioxidants, and inflammatory cytokines biomarkers.
Elgendy SA, Soliman MM, Shukry M, Mohammed LA, Nasr HE, Althobaiti S, Almalki DA, Alotaibi KS, Albattal SB, Elnoury HA. Elgendy SA, et al. Among authors: almalki da. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):8161. doi: 10.1007/s00210-024-03211-7. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38847832 No abstract available.
Screening impacts of Tilmicosin-induced hepatic and renal toxicity in rats: protection by Rhodiola rosea extract through the involvement of oxidative stress, antioxidants, and inflammatory cytokines biomarkers.
Elgendy SA, Soliman MM, Shukry M, Mohammed LA, Nasr HE, Althobaiti S, Almalki DA, Alotaibi KS, Albattal SB, Elnoury HA. Elgendy SA, et al. Among authors: almalki da. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7623-7637. doi: 10.1007/s00210-024-03089-5. Epub 2024 Apr 30. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38689072
Exploring the NRF2/HO-1 and NF-κB Pathways: Spirulina Nanoparticles as a Novel Approach to Combat Diabetic Nephropathy.
Althobaiti F, Taher ES, Ahmed Alkeridis L, Ibrahim AM, El-Shafai N, A Al-Shuraym L, Fericean L, Imbrea F, A Kassab M, Farrag FA, Abdeen A, Almalki DA, Al-Farga A, Afifi M, Shukry M. Althobaiti F, et al. Among authors: almalki da. ACS Omega. 2024 May 21;9(22):23949-23962. doi: 10.1021/acsomega.4c02285. eCollection 2024 Jun 4. ACS Omega. 2024. PMID: 38854532 Free PMC article.
12 results